With stringent regulatory requirements across large batch sizes, maintaining compliance can be challenging. Here, Körber's powerful and market-leading PAS-X MES Suite comes into play, digitalizing and automating documentation and reporting tasks, ensuring each of your batches adheres to Good Manufacturing Practice (GMP) standards.
Recent trends highlight a surge in demand for mass market medicines. This increase is driven by lessons from the Covid-19 pandemic, when vaccines had to be made available quickly in large quantities, but also from the ongoing need for diabetes or weight loss medication. GMP-compliance, quality control, risk of contamination as well as cost of production and time to market are some of the increasingly significant challenges that companies delivering large batch sizes are confronted by. Having a competent and efficient partner by your side, capable of addressing these challenges through top-notch integrated end-to-end solutions can elevate your mass production to new levels of efficiency and sustainable success. Here’s where the unique Körber Ecosystem approach comes into play – ensuring worldwide healthcare from the initial idea to the finished solution: with everything, effortlessly, in one place.
Highlights:
- What are the biggest challenges of pharma mass production?
- How to streamline your mass production and reduce complexity by leveraging the Körber Ecosystem approach?
- Which integrated end-to-end solutions does Körber offer?
Comments
No comments